Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|January 6, 2019
A successful compartmental approach for the treatment of breast cancer brain metastasesThuy T Nguyen, Eurydice Angeli, François Darrouzain, et al.
The Journal of Investigative Dermatology|November 25, 2019
Polyomavirus-Positive Merkel Cell Carcinoma Derived from a Trichoblastoma Suggests an Epithelial Origin of this Merkel Cell CarcinomaThibault Kervarrec, Mohanad Aljundi, Silke Appenzeller, et al.
Experimental Hematology & Oncology|May 15, 2023
Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatmentThi Oanh Bui, Eurydice Angeli, Morad El Bouchtaoui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2019
A Constitutional Activating MET Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory DiseasesMorad El Bouchtaoui, Marcio Do Cruzeiro, Christophe Leboeuf, et al.
International Journal of Clinical and Experimental Pathology|July 18, 2014
Stability of preclinical models of aggressive renal cell carcinomasMariana Varna, Guilhem Bousquet, Irmine Ferreira, et al.
Oncotarget|August 11, 2016
Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinibMaria Serova, Annemilaï Tijeras-Raballand, Celia Dos Santos, et al.
Experimental Hematology & Oncology|April 15, 2024
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastasesEurydice Angeli, Justine Paris, Olivier Le Tilly, et al.
Annales De Pathologie|March 21, 2017
[Results of the Massive Open Online Course (MOOC) on cancer diagnosis and evaluation of its impact on the perception of the pathology specialty]Charlotte Gardair, Guilhem Bousquet, Cédric de Bazelaire, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 30, 2026
Integrative and interactive genomic analyses guiding personalized combined therapy improve clinical benefit in metastatic patients: A monocentric real-life experienceJelena Filipovic, Emma Anjorand, Laetitia Marisa, et al.
The Oncologist|January 31, 2012
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO)Isabelle Ray-Coquard, Antoine Italiano, Emmanuelle Bompas, et al.
Pageof 9